RenovoRx, Inc. (RNXT) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$12.51M | -14.0% |
| 2024 | -$10.97M | +3.7% |
| 2023 | -$11.40M | -14.5% |
| 2022 | -$9.95M | -75.5% |
| 2021 | -$5.67M | -77.0% |
| 2020 | -$3.20M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$12.51M | -14.0% |
| 2024 | -$10.97M | +3.7% |
| 2023 | -$11.40M | -14.5% |
| 2022 | -$9.95M | -75.5% |
| 2021 | -$5.67M | -77.0% |
| 2020 | -$3.20M | — |